3,043,860 Common Shares of Tryp Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 18-DEC-2023. These Common Shares will be under lockup for 1096 days starting from 17-DEC-2020 to 18-DEC-2023.

Details:
All securities of an issuer owned or controlled by a Principal (as defined in NP 46-201) must be placed in escrow at the time the issuer distributes its securities or convertible securities to the public by prospectus pursuant to an initial public offering.